#Chemo drug shortage shows vulnerability of the #healthcare #supplychain
As #cisplatin became scarce, oncologists switched to #carboplatin, another common #cancer therapy, which Intas also produced. With Intas no longer producing carboplatin & increasing demand, that medicine is now also in short supply. It was βlike a ripple effect in the supply chain,β Socal says.
Survey of US cancer centers in May revealed that a whopping 93% were experiencing shortages of carboplatin.
https://www.technologyreview.com/2023/08/18/1078108/cancer-drug-shortage-supply-chain/
#chemo #healthcare #supplychain #cisplatin #carboplatin #cancer
RT @matteolambe@twitter.com
Finally the controversy on #carboplatin use as part of neoadjuvant #chemotherapy in triple-negative #BreastCancer patients is over: super congrats to our Indian colleagues for running such an important academic trial!
@OncoAlert@twitter.com @SABCSSanAntonio@twitter.com @Poggio_Fra@twitter.com #bcsm #SABCS22
π¦π: https://twitter.com/matteolambe/status/1601283365969465344
#carboplatin #chemotherapy #breastcancer #bcsm #SABCS22